Point of care sickle cell test
US9995757B2 · kind B2 · utility
0Cited by
3References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 9, 2014 |
| Grant date | Jun 12, 2018 |
| Priority date | — |
| Expiry date | Sep 9, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/22
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The disclosure provides methods, kits, and devices for determining an amount of hemoglobin S and/or an amount of total hemoglobin, and optionally, expressing the amount of hemoglobin S as a percentage. Devices of the disclosure may be used as point-of-care diagnostic systems accessible for use to a layperson, i.e., an individual with minimal or no medical training or expertise.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.